S&P 500   3,957.51 (+0.22%)
DOW   32,157.94 (+0.16%)
QQQ   309.60 (-0.05%)
AAPL   159.52 (+0.37%)
MSFT   278.69 (+0.37%)
META   205.13 (+0.42%)
GOOGL   105.04 (-0.53%)
AMZN   97.81 (-0.91%)
TSLA   189.67 (-1.33%)
NVDA   265.77 (-2.26%)
NIO   8.98 (-3.13%)
BABA   86.48 (-0.05%)
AMD   97.61 (-2.66%)
T   18.54 (+0.43%)
F   11.46 (+0.35%)
MU   60.76 (-0.95%)
CGC   1.91 (-0.10%)
GE   90.94 (-0.71%)
DIS   93.89 (-2.02%)
AMC   4.46 (-0.22%)
PFE   40.35 (+0.42%)
PYPL   73.59 (+1.42%)
NFLX   326.75 (+1.99%)
S&P 500   3,957.51 (+0.22%)
DOW   32,157.94 (+0.16%)
QQQ   309.60 (-0.05%)
AAPL   159.52 (+0.37%)
MSFT   278.69 (+0.37%)
META   205.13 (+0.42%)
GOOGL   105.04 (-0.53%)
AMZN   97.81 (-0.91%)
TSLA   189.67 (-1.33%)
NVDA   265.77 (-2.26%)
NIO   8.98 (-3.13%)
BABA   86.48 (-0.05%)
AMD   97.61 (-2.66%)
T   18.54 (+0.43%)
F   11.46 (+0.35%)
MU   60.76 (-0.95%)
CGC   1.91 (-0.10%)
GE   90.94 (-0.71%)
DIS   93.89 (-2.02%)
AMC   4.46 (-0.22%)
PFE   40.35 (+0.42%)
PYPL   73.59 (+1.42%)
NFLX   326.75 (+1.99%)
S&P 500   3,957.51 (+0.22%)
DOW   32,157.94 (+0.16%)
QQQ   309.60 (-0.05%)
AAPL   159.52 (+0.37%)
MSFT   278.69 (+0.37%)
META   205.13 (+0.42%)
GOOGL   105.04 (-0.53%)
AMZN   97.81 (-0.91%)
TSLA   189.67 (-1.33%)
NVDA   265.77 (-2.26%)
NIO   8.98 (-3.13%)
BABA   86.48 (-0.05%)
AMD   97.61 (-2.66%)
T   18.54 (+0.43%)
F   11.46 (+0.35%)
MU   60.76 (-0.95%)
CGC   1.91 (-0.10%)
GE   90.94 (-0.71%)
DIS   93.89 (-2.02%)
AMC   4.46 (-0.22%)
PFE   40.35 (+0.42%)
PYPL   73.59 (+1.42%)
NFLX   326.75 (+1.99%)
S&P 500   3,957.51 (+0.22%)
DOW   32,157.94 (+0.16%)
QQQ   309.60 (-0.05%)
AAPL   159.52 (+0.37%)
MSFT   278.69 (+0.37%)
META   205.13 (+0.42%)
GOOGL   105.04 (-0.53%)
AMZN   97.81 (-0.91%)
TSLA   189.67 (-1.33%)
NVDA   265.77 (-2.26%)
NIO   8.98 (-3.13%)
BABA   86.48 (-0.05%)
AMD   97.61 (-2.66%)
T   18.54 (+0.43%)
F   11.46 (+0.35%)
MU   60.76 (-0.95%)
CGC   1.91 (-0.10%)
GE   90.94 (-0.71%)
DIS   93.89 (-2.02%)
AMC   4.46 (-0.22%)
PFE   40.35 (+0.42%)
PYPL   73.59 (+1.42%)
NFLX   326.75 (+1.99%)
NASDAQ:ACER

Acer Therapeutics - ACER Earnings Date, Estimates & Call Transcripts

$0.75
-0.02 (-2.59%)
(As of 03/24/2023 02:15 PM ET)
Add
Compare
Today's Range
$0.75
$0.80
50-Day Range
$0.67
$3.00
52-Week Range
$0.65
$4.56
Volume
72,701 shs
Average Volume
467,553 shs
Market Capitalization
$15.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Skip Charts & View Estimated and Actual Earnings Data

ACER Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ACER Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Acer Therapeutics Analyst Forecasts

Current Year EPS Consensus Estimate: $-1.62 EPS
Next Year EPS Consensus Estimate: $-0.23 EPS

ACER Earnings Date and Information

Acer Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 29th, 2023 based off prior year's report dates.

Acer Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/29/2023
(Estimated)
        
3/24/2023($0.37)($0.37)
11/14/2022Q3 2022($0.76)($0.31)+$0.45($0.31)
8/15/2022Q2 2022($0.58)($0.48)+$0.10($0.79)
5/16/2022Q1 2022($0.18)($0.49)($0.31)($0.34)
3/2/2022Q4 2021($0.08)($0.31)($0.23)($0.31)$5.00 million$0.36 million
11/19/20219/30/2021($0.28)($0.23)+$0.05($0.23)
8/9/20216/30/2021($0.36)($0.23)+$0.13($0.23)
5/16/20213/31/2021($0.44)($0.11)+$0.33($0.11)$2.00 million$4.00 million
2/28/202112/31/2020($0.41)($0.50)($0.09)($0.50)
11/15/20209/30/2020($0.46)($0.51)($0.05)($0.51)  
8/13/2020Q2 2020($0.3760)($0.56)($0.1840)($0.56)
5/14/20203/31/2020($0.40)($0.49)($0.09)($0.49)
3/18/202012/31/2019($0.48)($0.51)($0.03)($0.51)
11/13/2019Q3 2019($0.57)($0.52)+$0.05($0.52)
8/13/2019Q2 2019($0.7820)($1.09)($0.3080)($1.09)
5/14/20193/31/2019($0.83)($0.79)+$0.04($0.79)
3/7/2019Q4($0.4630)($0.85)($0.3870)($0.85)
11/12/20189/30/2018($0.53)($0.43)+$0.10($0.43)
8/13/2018Q2 2018($0.5450)($0.64)($0.0950)($0.64)
5/14/2018Q1 2018($0.69)($0.53)+$0.16($0.53)
3/7/2018Q4 2017($0.53)($0.63)($0.10)($0.63)
11/13/2017Q3 2017($1.09)($1.09)($1.09)
8/14/2017Q2 2017($0.93)($0.93)($0.93)
5/12/2017Q1 2017($0.12)($0.12)($0.12)
3/28/2017Q4 2016($1.04)($1.04)$0.40$0.73 million
11/14/2016Q3 2016($2.90)($2.90)($2.90)$0.73 million
8/11/2016Q2 2016($6.63)($3.11)+$3.52($3.11)$0.73 million$0.73 million  
5/12/2016Q1 2016($6.73)($3.21)+$3.52($3.21)$0.73 million$0.73 million  
3/15/2016Q4 2015($6.21)($3.11)+$3.10($3.11)$0.73 million$0.73 million  
11/10/2015Q3 2015($6.63)($4.35)+$2.28($4.35)$0.73 million$0.73 million
8/12/2015Q2 2015($5.80)($5.80)($5.80)$0.73 million  
5/12/2015Q1 2015($9.94)($9.94)($9.94)$0.38 million  
2/23/2015Q4 2014($9.94)($9.94)($9.94)$0.31 million
11/6/2014Q3 2014($12.42)($11.59)+$0.83($11.59)$0.30 million$0.31 million
8/14/2014Q2 2014($9.11)($12.42)($3.31)($12.42)$0.30 million$0.31 million
5/14/2014Q1 2014($10.77)($10.77)($10.77)$0.22 million$0.35 million  
11/7/2013Q3 2013($32.30)($32.30)($32.30)$0.35 million
8/14/2013Q2 2013($30.64)($30.64)($30.64)$0.35 million
5/14/2013Q1 2013($48.03)($48.03)($48.03)$0.22 million
11/14/2012Q312($0.10)($0.10)
8/13/2012Q2 2012($31.14)($31.14)($31.14)
5/11/2012Q1 2012($34.12)($34.12)($34.12)
2/27/2012Q4 2011($26.50)($26.50)($26.50)
11/4/2011Q3 2011($18.55)($18.55)($18.55)
8/11/2011Q2 2011($21.20)($21.20)($21.20)
5/6/2011Q1 2011($20.54)($20.54)($20.54)
3/8/2011Q4 2010($16.56)($16.56)($16.56)
11/9/2010Q3 2010($23.19)($23.19)($23.19)
8/6/2010Q2 2010($26.50)($38.10)($11.60)($38.10)
5/13/2010Q1 2010($26.50)($30.48)($3.98)($30.48)
3/5/2010Q4 2009($29.81)($29.81)($29.81)
11/4/2009Q3 2009$7.29+$7.29($31.80)
8/13/2009Q2 2009($2,030.97)($2,030.97)($4,038.42)
5/15/2009Q1 2009($44.39)($44.39)($44.39)
4/16/2009Q4 2008($43.06)($43.06)($43.06)
10/23/2008Q3 2008($102.69)($91.10)+$11.59($91.10)
8/14/2008Q2 2008($125.88)($117.93)+$7.95($117.93)
5/13/2008Q1 2008($162.32)($123.56)+$38.76($123.56)
3/18/2008Q4 2007($188.82)($188.82)($188.82)












Acer Therapeutics Earnings - Frequently Asked Questions

When is Acer Therapeutics's earnings date?

Acer Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 29th, 2023 based off last year's report dates. Learn more on ACER's earnings history.

How much revenue does Acer Therapeutics generate each year?

Acer Therapeutics (NASDAQ:ACER) has a recorded annual revenue of $1.26 million.

How much profit does Acer Therapeutics generate each year?

Acer Therapeutics (NASDAQ:ACER) has a recorded net income of -$15.37 million. ACER has generated -$1.43 earnings per share over the last four quarters.

What is Acer Therapeutics's EPS forecast for next year?

Acer Therapeutics's earnings are expected to grow from ($1.62) per share to ($0.23) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:ACER) was last updated on 3/24/2023 by MarketBeat.com Staff